"In Vivo Synergy of IL-21 Plus IL-2 in A Murine Transgenic pmel-1 Therapeutic Melanoma Tumor Model Results in Significant Anti-Tumor Immunity and Durable Long-Term Curative Effect" by Edwin B Walker

Selected Works of Walter J. Urba, MD, PhD

Article

In Vivo Synergy of IL-21 Plus IL-2 in A Murine Transgenic pmel-1 Therapeutic Melanoma Tumor Model Results in Significant Anti-Tumor Immunity and Durable Long-Term Curative Effect

Journal of Immunotherapy (2005)

Edwin B Walker, Providence Portland Medical Center
Hong He, National Institutes of Health
Guojun Yang, Texas A&M University
Hong-Ming Hu, Providence Portland Medical Center
Christopher H Clegg, ZymoGenetics
Ketura Wisner, Providence Portland Medical Center
Walter J Urba, Providence Portland Medical Center

Link

Disciplines

Publication Date

January 11, 2005

DOI

10.1097/01.cji.0000190974.93223.69

Citation Information

Edwin B Walker, Hong He, Guojun Yang, Hong-Ming Hu, et al.. "In Vivo Synergy of IL-21 Plus IL-2 in A Murine Transgenic pmel-1 Therapeutic Melanoma Tumor Model Results in Significant Anti-Tumor Immunity and Durable Long-Term Curative Effect" Journal of Immunotherapy Vol. 28 Iss. 6 (2005) p. 621
Available at: http://works.bepress.com/walter-urba/201/